Tag Archives: gild

Gilead’s Hep C Combo Pill Harvoni Approved, Priced

The FDA approved Gilead Sciences’ (GILD) hepatitis C combo pill Harvoni Friday afternoon, in a widely expected but still crucial step for a drug expected to be a megablockbuster. Gilead also disclosed the drug’s price for the first time, at $94,500 for a 12-week course. Harvoni is a combination of ledipasvir and sofosbuvir, the latter already being sold solo under the brand name Sovaldi. Sovaldi, launched in December, has already raked in a

Video: 3 Big Cap Biotechs Bucking Market Correction

Though the market is in a correction, there are several big cap medical stocks bucking the downtrend. IBD TV’s Alissa Williams breaks down the top three: Gilead Sciences (GILD), Actavis (ACT) and Alexion Pharmaceuticals (ALXN). Follow Alissa Williams on Twitter: @IBD_AWilliams .

Meet 5 Top Stocks With Rising Earnings Estimates

With earnings season set for kickoff, analysts are sizing up companies to adjust their stock forecasts. Today’s Screen Of The Day is Leaders With Rising Estimates: stocks like Gilead Sciences (GILD) that are seeing analysts raise their earnings estimates. A second sort finds the top five companies on the list by estimated earnings-per-share growth this quarter. Gilead Sciences Gilead (GILD) tops the Leaders list and is projected to see a 267% jump